SEARCH LISTED OR DELISTED COMPANY

Any AUS or NZ company

BROWSE

Browse Australian delisted companies

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Browse terminated Australian managed funds

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
SEARCH PRIVATE COMPANY

SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

CANNPAL ANIMAL THERAPEUTICS LIMITED (CP1)

Click here for free access to this company's:
ASX, Legal & CGT Status

SHARE PRICES

(updated at weekends)

Former (or subsequent) names

 

Shareholder links

Our website ranking of CP1: rating 2
(2 out of 5)
COMPANY WEBSITE:

 

REGISTRY:
Computershare Investor Services, Level 11 172 St Georges Terrace Perth WA 6000
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 7 3229 9860
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000CP17
Address: Level 3, 43a Bay Street, Double Bay 2028
Tel:  +61 2 6108 3622 Fax: 

Date first listed: 25/10/2017
Company Secretary: Baden Bowen
Sector: Pharmaceuticals, Biotechnology & Life Sciences
Industry Group: 
Activities: Biomedical Research Animal Pharmaceuticals

delisted from the close of trading on Thursday, 18 March 2021, pursuant to Listing rule 17.11.

18/03/2021

we understand AusCann Group Holdings Limited acquired all of the issued shares in CP1 and issued 1.3 fully paid ordinary shares in AusCann for every CannPal share held as at the Scheme record date being 7pm (AEDT) on 15 March 2021

18/03/2021

Eligible former CannPal shareholders have been issued 1.3 fully paid ordinary shares in AusCann for every CannPal share they held as at the Scheme record date being 7pm (AEDT) on 15 March 2021. AusCann has issued a total of 123,499,753 new ordinary shares in AusCann to former CannPal shareholders as consideration for the transfer of their CannPal shares to AusCann. Eligible former CannPal shareholders will be sent holding statements recording the number of new AusCann shares issued to the holder under the Scheme.

18/03/2021

CannPal Animal Therapeutics Limited today implemented its scheme of arrangement under which CannPal shareholders received 1.3 new fully paid ordinary shares in AusCann for every 1 fully paid ordinary share held in CannPal at 7.00pm (AEDT) on 15 March 2021. All fully paid ordinary shares in CannPal were transferred to AusCann and CannPal is now a wholly owned subsidiary of AusCann and will be removed from the official list of the ASX shortly.

18/03/2021

The securities of CannPal Animal Therapeutics Limited will be suspended from quotation at the close of trading today, Thursday, 11 March 2021, in accordance with Listing Rule 17.2, following lodgement of the Supreme Court of Western Australia's orders with the Australian Securities and Investments Commission approving the scheme of arrangement by which AusCann Group Holdings Limited will acquire all of the issued shares in CP1.

11/03/2021

listed entity carried for record purposes only

25/10/2017

ASX Announcements (courtesy of ASX)

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box. If an image appears, enter the word/figures you see in the image.

    loading Posting your comments. Please wait...

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNATURENUMBERPRICEAMOUNT
    09/12/2019Layton Mills44,000$0.115$5,060
    09/12/2019Layton Mills38,337$0.115$4,409
    05/12/2019Layton Mills47,663$0.119$5,691
    21/11/2019Geoff Starr120,000$0.123$14,798
    24/05/2019Layton Mills104,500$0.145$15,153

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Geoff StarrChairman23/04/2017
    Layton MillsManaging Director, CEO05/06/2017
    Baden BowenCFO25/10/2017
    Rob CliffordNon Exec Director03/02/2017
    Kate AdamsNon Exec Director23/04/2017

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Max JohnstonNon Exec Director25/10/201703/09/2020

    Date of first appointment, title may have changed.